Research Summary
Classical Swine Fever (CSF) vaccines are used to prevent infection by the Classical Swine Fever virus. CSF is a highly contagious and fatal viral disease primarily affecting pigs, especially domestic pigs and wild boars, and can lead to widespread outbreaks. The disease spreads through direct contact or airborne transmission and can rapidly infect entire herds. Classical Swine Fever vaccines help stimulate the pig＇s immune system to produce antibodies against the virus, thus enhancing immunity to the disease. The vaccines can be either live attenuated or inactivated virus vaccines, with the former mimicking natural infection to generate a stronger immune response, while the latter reduces the risk of infection by using a killed virus. Classical Swine Fever vaccines are widely used worldwide, particularly in countries with large pig farming industries, to control the spread of the disease and minimize economic losses.
According to WENKH research statistics, the global Classical Swine Fever Vaccines market size will reach 195.82 Million USD in 2026 and is projected to reach 276.09 Million USD by 2033, with a CAGR of 5.03% (2026-2033). Among them, the Asia-Pacific Classical Swine Fever Vaccines market is undergoing rapid changes, reaching Million USD in 2026, accounting for approximately % of the global market share. It is projected to reach Million USD by 2033.
The global Classical Swine Fever Vaccines market is highly competitive, with key market players including Winsun Bio-Pharmaceutical, MSD Animal Health, CAHIC, Tecon, SPAH, Boehringer Ingelheim, Ceva, Harbin Weike BIOTECHNOLOGY, Qilu Animal Health Products, Ringpu Bio-Technology, DaHuaNong Animal Health Products, CAVAC, Komipharm, Agrovet, Bioveta, Jinyu Bio-Technology, Institutul Pasteur, MVP, etc. This report categorizes the competitive landscape of the global Classical Swine Fever Vaccines market into three tiers based on annual revenue, with the top three market players holding approximately % of the total market share.
This report provides an in-depth analysis of the global Classical Swine Fever Vaccines market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, sales revenue, and gross profit margin of major players in the global Classical Swine Fever Vaccines industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different product segments of Classical Swine Fever Vaccines and their downstream application fields.
In terms of data, this report includes a comprehensive time-series dataset. The historical data spans from 2021 to 2025, providing a solid foundation for analyzing past market trends. The year 2026 is used as a base year to accurately assess the current market landscape. Forecast data covers the period from 2027 to 2033, utilizing scientific analysis methods and models to offer forward-looking predictions and insights into the market's future development. This provides valuable reference information for industry participants and stakeholders.
The report covers countries including United States, China, Germany, Japan, France, South Korea, United Kingdom, India, Italy, Brazil, Mexico, Indonesia, Vietnam and South Africa. It particularly focuses on the sales revenue of Classical Swine Fever Vaccines in these countries, as well as the product segmentation and downstream application market size of each country. The report provides an in-depth analysis of the regional distribution and future development trends of the Classical Swine Fever Vaccines market. By considering local policies, this report evaluates the market prospects of Classical Swine Fever Vaccines in each country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.
This report places a strong emphasis on data quality and reliability, utilizing diverse and extensive data sources to ensure the accuracy and validity of the information presented. Primary data collection involves multiple channels, including in-depth interviews with senior executives, industry experts, supply chain stakeholders, and end consumers. These interviews provide key insights into corporate strategic planning, industry policy interpretation, supply chain dynamics, and end-user experiences. Secondary data sources cover a wide range of authoritative statistics from government agencies, customs databases, industry associations, third-party paid databases, brokerage research reports, academic research findings, corporate annual reports, financial statements, real-time news updates, and relevant information from international organizations. These data sources serve as a solid foundation for verification and analysis.
Companies Covered
Winsun Bio-Pharmaceutical
MSD Animal Health
CAHIC
Tecon
SPAH
Boehringer Ingelheim
Ceva
Harbin Weike BIOTECHNOLOGY
Qilu Animal Health Products
Ringpu Bio-Technology
DaHuaNong Animal Health Products
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Product Segment
C-Strain Live Attenuated Vaccine
Thiverval Strain Vaccine
Others
Product Application
Government Tender
Market Sales
Chapter Scope
Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects
Chapter 2: Global Classical Swine Fever Vaccines Industry Chain Analysis
Chapter 3: Global Classical Swine Fever Vaccines Industry Environment Analysis and Porter's Five Forces Analysis
Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global Classical Swine Fever Vaccines Market (Market Share, Product Revenue Comparison, Tier Division, Corporate Expansion and M&A Trends)
Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Specifications and Features, Product Revenue and Product Gross Profit Margin)
Chapter 6: Global Classical Swine Fever Vaccines Market Analysis by Countries, Product Segment and Downstream Application
Chapter 7: United States Classical Swine Fever Vaccines Market Size, Product Segment, Downstream Application Analysis
Chapter 8: China Classical Swine Fever Vaccines Market Size, Product Segment, Downstream Application Analysis
Chapter 9: Germany Classical Swine Fever Vaccines Market Size, Product Segment, Downstream Application Analysis
Chapter 10: Japan Classical Swine Fever Vaccines Market Size, Product Segment, Downstream Application Analysis
Chapter 11: France Classical Swine Fever Vaccines Market Size, Product Segment, Downstream Application Analysis
Chapter 12: South Korea Classical Swine Fever Vaccines Market Size, Product Segment, Downstream Application Analysis
Chapter 13: United Kingdom Classical Swine Fever Vaccines Market Size, Product Segment, Downstream Application Analysis
Chapter 14: India Classical Swine Fever Vaccines Market Size, Product Segment, Downstream Application Analysis
Chapter 15: Italy Classical Swine Fever Vaccines Market Size, Product Segment, Downstream Application Analysis
Chapter 16: Brazil Classical Swine Fever Vaccines Market Size, Product Segment, Downstream Application Analysis
Chapter 17: Mexico Classical Swine Fever Vaccines Market Size, Product Segment, Downstream Application Analysis
Chapter 18: Indonesia Classical Swine Fever Vaccines Market Size, Product Segment, Downstream Application Analysis
Chapter 19: Vietnam Classical Swine Fever Vaccines Market Size, Product Segment, Downstream Application Analysis
Chapter 20: South Africa Classical Swine Fever Vaccines Market Size, Product Segment, Downstream Application Analysis
Chapter 21: Research Conclusion
Chapter 22: Methodology and Data Source
Purpose and Value of the Report
Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.
Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.
Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.
Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.
Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.
Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.
Table of Content
1 Classical Swine Fever Vaccines Market Overview
1.1 Product Definition Introduction
1.2 Global Classical Swine Fever Vaccines Market Size and Growth Forecast Analysis (2021-2033)
1.3 Classical Swine Fever Vaccines Market Status and Development Prospects
1.3.1 Classical Swine Fever Vaccines Market Status
1.3.2 Classical Swine Fever Vaccines Industry Development Prospects
1.4 Classical Swine Fever Vaccines Market Overview by Product Segment
1.4.1 Global Classical Swine Fever Vaccines Market Size and Growth Forecast Analysis by Product Segment: 2021 VS 2026 VS 2033
1.4.2 C-Strain Live Attenuated Vaccine
1.4.3 Thiverval Strain Vaccine
1.4.4 Others
1.5 Classical Swine Fever Vaccines Market Overview by Product Application
1.5.1 Global Classical Swine Fever Vaccines Market Size and Growth Forecast Analysis by Product Application: 2021 VS 2026 VS 2033
1.5.2 Government Tender
1.5.3 Market Sales
2 Classical Swine Fever Vaccines Industry Supply Chain Analysis
2.1 Classical Swine Fever Vaccines Supply Chain
2.2 Classical Swine Fever Vaccines Midstream Suppliers
2.3 Classical Swine Fever Vaccines Downstream Customers
2.4 Classical Swine Fever Vaccines Sales Channel Analysis
3 Classical Swine Fever Vaccines Market Environment Analysis
3.1 Classical Swine Fever Vaccines Industry Policy Analysis
3.2 Classical Swine Fever Vaccines Emerging Technology Trends in the Industry
3.3 Classical Swine Fever Vaccines Restraining Factors Analysis
3.4 Classical Swine Fever Vaccines Market Porter's Five Forces Analysis
3.4.1 Competitive Rivalry
3.4.2 Threat of New Entrants
3.4.3 Bargaining Power of Suppliers
3.4.4 Bargaining Power of Buyers
3.4.5 Threat of Substitute Products or Services
4 Global Classical Swine Fever Vaccines Market Players Competition Landscape
4.1 Global Classical Swine Fever Vaccines Market Revenue by Key Players (2021-2026)
4.2 Global Classical Swine Fever Vaccines Market Position by Key Players
4.3 Global Key Players Headquarter and Key Area Served
4.4 Global Classical Swine Fever Vaccines Market Expansion and M&A Dynamic
5 In-depth Analysis of Key Players
5.1 Winsun Bio-Pharmaceutical
5.1.1 Winsun Bio-Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.1.2 Winsun Bio-Pharmaceutical Classical Swine Fever Vaccines Product Features
5.1.3 Winsun Bio-Pharmaceutical Classical Swine Fever Vaccines Product Revenue and Gross Margin Analysis (2021-2026)
5.2 MSD Animal Health
5.2.1 MSD Animal Health Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.2.2 MSD Animal Health Classical Swine Fever Vaccines Product Features
5.2.3 MSD Animal Health Classical Swine Fever Vaccines Product Revenue and Gross Margin Analysis (2021-2026)
5.3 CAHIC
5.3.1 CAHIC Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.3.2 CAHIC Classical Swine Fever Vaccines Product Features
5.3.3 CAHIC Classical Swine Fever Vaccines Product Revenue and Gross Margin Analysis (2021-2026)
5.4 Tecon
5.4.1 Tecon Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.4.2 Tecon Classical Swine Fever Vaccines Product Features
5.4.3 Tecon Classical Swine Fever Vaccines Product Revenue and Gross Margin Analysis (2021-2026)
5.5 SPAH
5.5.1 SPAH Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.5.2 SPAH Classical Swine Fever Vaccines Product Features
5.5.3 SPAH Classical Swine Fever Vaccines Product Revenue and Gross Margin Analysis (2021-2026)
5.6 Boehringer Ingelheim
5.6.1 Boehringer Ingelheim Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.6.2 Boehringer Ingelheim Classical Swine Fever Vaccines Product Features
5.6.3 Boehringer Ingelheim Classical Swine Fever Vaccines Product Revenue and Gross Margin Analysis (2021-2026)
5.7 Ceva
5.7.1 Ceva Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.7.2 Ceva Classical Swine Fever Vaccines Product Features
5.7.3 Ceva Classical Swine Fever Vaccines Product Revenue and Gross Margin Analysis (2021-2026)
5.8 Harbin Weike BIOTECHNOLOGY
5.8.1 Harbin Weike BIOTECHNOLOGY Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.8.2 Harbin Weike BIOTECHNOLOGY Classical Swine Fever Vaccines Product Features
5.8.3 Harbin Weike BIOTECHNOLOGY Classical Swine Fever Vaccines Product Revenue and Gross Margin Analysis (2021-2026)
5.9 Qilu Animal Health Products
5.9.1 Qilu Animal Health Products Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.9.2 Qilu Animal Health Products Classical Swine Fever Vaccines Product Features
5.9.3 Qilu Animal Health Products Classical Swine Fever Vaccines Product Revenue and Gross Margin Analysis (2021-2026)
5.10 Ringpu Bio-Technology
5.10.1 Ringpu Bio-Technology Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.10.2 Ringpu Bio-Technology Classical Swine Fever Vaccines Product Features
5.10.3 Ringpu Bio-Technology Classical Swine Fever Vaccines Product Revenue and Gross Margin Analysis (2021-2026)
5.11 DaHuaNong Animal Health Products
5.11.1 DaHuaNong Animal Health Products Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.11.2 DaHuaNong Animal Health Products Classical Swine Fever Vaccines Product Features
5.11.3 DaHuaNong Animal Health Products Classical Swine Fever Vaccines Product Revenue and Gross Margin Analysis (2021-2026)
5.12 CAVAC
5.12.1 CAVAC Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.12.2 CAVAC Classical Swine Fever Vaccines Product Features
5.12.3 CAVAC Classical Swine Fever Vaccines Product Revenue and Gross Margin Analysis (2021-2026)
5.13 Komipharm
5.13.1 Komipharm Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.13.2 Komipharm Classical Swine Fever Vaccines Product Features
5.13.3 Komipharm Classical Swine Fever Vaccines Product Revenue and Gross Margin Analysis (2021-2026)
5.14 Agrovet
5.14.1 Agrovet Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.14.2 Agrovet Classical Swine Fever Vaccines Product Features
5.14.3 Agrovet Classical Swine Fever Vaccines Product Revenue and Gross Margin Analysis (2021-2026)
5.15 Bioveta
5.15.1 Bioveta Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.15.2 Bioveta Classical Swine Fever Vaccines Product Features
5.15.3 Bioveta Classical Swine Fever Vaccines Product Revenue and Gross Margin Analysis (2021-2026)
5.16 Jinyu Bio-Technology
5.16.1 Jinyu Bio-Technology Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.16.2 Jinyu Bio-Technology Classical Swine Fever Vaccines Product Features
5.16.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Product Revenue and Gross Margin Analysis (2021-2026)
5.17 Institutul Pasteur
5.17.1 Institutul Pasteur Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.17.2 Institutul Pasteur Classical Swine Fever Vaccines Product Features
5.17.3 Institutul Pasteur Classical Swine Fever Vaccines Product Revenue and Gross Margin Analysis (2021-2026)
5.18 MVP
5.18.1 MVP Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.18.2 MVP Classical Swine Fever Vaccines Product Features
5.18.3 MVP Classical Swine Fever Vaccines Product Revenue and Gross Margin Analysis (2021-2026)
6 Global Classical Swine Fever Vaccines Market Analysis by Countries, by Product Segment and Application
6.1 Global Classical Swine Fever Vaccines Market Size and Growth Forecast by Countries: 2021 VS 2026 VS 2033
6.1.1 Global Classical Swine Fever Vaccines Market Revenue by Countries (2021-2026)
6.1.2 Global Classical Swine Fever Vaccines Market Revenue Forecast by Countries (2027-2033)
6.2 Global Classical Swine Fever Vaccines Market Size by Product Segment (2021-2033)
6.3 Global Classical Swine Fever Vaccines Market Size by Product Application (2021-2033)
7 United States Classical Swine Fever Vaccines Market Analysis
7.1 United States Classical Swine Fever Vaccines Market Prospects
7.2 United States Classical Swine Fever Vaccines Market Size by Product Segment (2021-2033)
7.3 United States Classical Swine Fever Vaccines Market Size by Product Application (2021-2033)
8 China Classical Swine Fever Vaccines Market Analysis
8.1 China Classical Swine Fever Vaccines Market Prospects
8.2 China Classical Swine Fever Vaccines Market Size by Product Segment (2021-2033)
8.3 China Classical Swine Fever Vaccines Market Size by Product Application (2021-2033)
9 Germany Classical Swine Fever Vaccines Market Analysis
9.1 Germany Classical Swine Fever Vaccines Market Prospects
9.2 Germany Classical Swine Fever Vaccines Market Size by Product Segment (2021-2033)
9.3 Germany Classical Swine Fever Vaccines Market Size by Product Application (2021-2033)
10 Japan Classical Swine Fever Vaccines Market Analysis
10.1 Japan Classical Swine Fever Vaccines Market Prospects
10.2 Japan Classical Swine Fever Vaccines Market Size by Product Segment (2021-2033)
10.3 Japan Classical Swine Fever Vaccines Market Size by Product Application (2021-2033)
11 France Classical Swine Fever Vaccines Market Analysis
11.1 France Classical Swine Fever Vaccines Market Prospects
11.2 France Classical Swine Fever Vaccines Market Size by Product Segment (2021-2033)
11.3 France Classical Swine Fever Vaccines Market Size by Product Application (2021-2033)
12 South Korea Classical Swine Fever Vaccines Market Analysis
12.1 South Korea Classical Swine Fever Vaccines Market Prospects
12.2 South Korea Classical Swine Fever Vaccines Market Size by Product Segment (2021-2033)
12.3 South Korea Classical Swine Fever Vaccines Market Size by Product Application (2021-2033)
13 United Kingdom Classical Swine Fever Vaccines Market Analysis
13.1 United Kingdom Classical Swine Fever Vaccines Market Prospects
13.2 United Kingdom Classical Swine Fever Vaccines Market Size by Product Segment (2021-2033)
13.3 United Kingdom Classical Swine Fever Vaccines Market Size by Product Application (2021-2033)
14 India Classical Swine Fever Vaccines Market Analysis
14.1 India Classical Swine Fever Vaccines Market Prospects
14.2 India Classical Swine Fever Vaccines Market Size by Product Segment (2021-2033)
14.3 India Classical Swine Fever Vaccines Market Size by Product Application (2021-2033)
15 Italy Classical Swine Fever Vaccines Market Analysis
15.1 Italy Classical Swine Fever Vaccines Market Prospects
15.2 Italy Classical Swine Fever Vaccines Market Size by Product Segment (2021-2033)
15.3 Italy Classical Swine Fever Vaccines Market Size by Product Application (2021-2033)
16 Brazil Classical Swine Fever Vaccines Market Analysis
16.1 Brazil Classical Swine Fever Vaccines Market Prospects
16.2 Brazil Classical Swine Fever Vaccines Market Size by Product Segment (2021-2033)
16.3 Brazil Classical Swine Fever Vaccines Market Size by Product Application (2021-2033)
17 Mexico Classical Swine Fever Vaccines Market Analysis
17.1 Mexico Classical Swine Fever Vaccines Market Prospects
17.2 Mexico Classical Swine Fever Vaccines Market Size by Product Segment (2021-2033)
17.3 Mexico Classical Swine Fever Vaccines Market Size by Product Application (2021-2033)
18 Indonesia Classical Swine Fever Vaccines Market Analysis
18.1 Indonesia Classical Swine Fever Vaccines Market Prospects
18.2 Indonesia Classical Swine Fever Vaccines Market Size by Product Segment (2021-2033)
18.3 Indonesia Classical Swine Fever Vaccines Market Size by Product Application (2021-2033)
19 Vietnam Classical Swine Fever Vaccines Market Analysis
19.1 Vietnam Classical Swine Fever Vaccines Market Prospects
19.2 Vietnam Classical Swine Fever Vaccines Market Size by Product Segment (2021-2033)
19.3 Vietnam Classical Swine Fever Vaccines Market Size by Product Application (2021-2033)
20 South Africa Classical Swine Fever Vaccines Market Analysis
20.1 South Africa Classical Swine Fever Vaccines Market Prospects
20.2 South Africa Classical Swine Fever Vaccines Market Size by Product Segment (2021-2033)
20.3 South Africa Classical Swine Fever Vaccines Market Size by Product Application (2021-2033)
21 Research Conclusion
22 Appendix
22.1 Methodology/Research Approach
22.2 Research Landscape
22.3 Research Benchmark and Hypothesis
22.4 Data Source
22.4.1 Primary Sources
22.4.2 Secondary Sources
22.5 Data Cross Validation
22.6 Disclaimer
Table 1：Global Classical Swine Fever Vaccines Market Size and Growth Forecast Analysis by Product Segment (2021 VS 2026 VS 2033) & (Million USD)
Table 2：Global Classical Swine Fever Vaccines Market Size and Growth Forecast Analysis by Product Application (2021 VS 2026 VS 2033) & (Million USD)
Table 3：Classical Swine Fever Vaccines Downstream Customers List
Table 4：Classical Swine Fever Vaccines Distributors/Dealers List
Table 5：Global Classical Swine Fever Vaccines Market Revenue by Key Players (2021-2026) & (Million USD)
Table 6：Global Classical Swine Fever Vaccines Market Position by Key Players
Table 7：Global Key Players Headquarter and Key Area Served
Table 8：Global Classical Swine Fever Vaccines Market Expansion and M&A Dynamic
Table 9：Winsun Bio-Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 10：Winsun Bio-Pharmaceutical Classical Swine Fever Vaccines Product Features
Table 11：Winsun Bio-Pharmaceutical Classical Swine Fever Vaccines Revenue (Million USD) and Gross Margin (2021-2026)
Table 12：MSD Animal Health Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 13：MSD Animal Health Classical Swine Fever Vaccines Product Features
Table 14：MSD Animal Health Classical Swine Fever Vaccines Revenue (Million USD) and Gross Margin (2021-2026)
Table 15：CAHIC Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 16：CAHIC Classical Swine Fever Vaccines Product Features
Table 17：CAHIC Classical Swine Fever Vaccines Revenue (Million USD) and Gross Margin (2021-2026)
Table 18：Tecon Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 19：Tecon Classical Swine Fever Vaccines Product Features
Table 20：Tecon Classical Swine Fever Vaccines Revenue (Million USD) and Gross Margin (2021-2026)
Table 21：SPAH Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 22：SPAH Classical Swine Fever Vaccines Product Features
Table 23：SPAH Classical Swine Fever Vaccines Revenue (Million USD) and Gross Margin (2021-2026)
Table 24：Boehringer Ingelheim Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 25：Boehringer Ingelheim Classical Swine Fever Vaccines Product Features
Table 26：Boehringer Ingelheim Classical Swine Fever Vaccines Revenue (Million USD) and Gross Margin (2021-2026)
Table 27：Ceva Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 28：Ceva Classical Swine Fever Vaccines Product Features
Table 29：Ceva Classical Swine Fever Vaccines Revenue (Million USD) and Gross Margin (2021-2026)
Table 30：Harbin Weike BIOTECHNOLOGY Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 31：Harbin Weike BIOTECHNOLOGY Classical Swine Fever Vaccines Product Features
Table 32：Harbin Weike BIOTECHNOLOGY Classical Swine Fever Vaccines Revenue (Million USD) and Gross Margin (2021-2026)
Table 33：Qilu Animal Health Products Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 34：Qilu Animal Health Products Classical Swine Fever Vaccines Product Features
Table 35：Qilu Animal Health Products Classical Swine Fever Vaccines Revenue (Million USD) and Gross Margin (2021-2026)
Table 36：Ringpu Bio-Technology Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 37：Ringpu Bio-Technology Classical Swine Fever Vaccines Product Features
Table 38：Ringpu Bio-Technology Classical Swine Fever Vaccines Revenue (Million USD) and Gross Margin (2021-2026)
Table 39：DaHuaNong Animal Health Products Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 40：DaHuaNong Animal Health Products Classical Swine Fever Vaccines Product Features
Table 41：DaHuaNong Animal Health Products Classical Swine Fever Vaccines Revenue (Million USD) and Gross Margin (2021-2026)
Table 42：CAVAC Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 43：CAVAC Classical Swine Fever Vaccines Product Features
Table 44：CAVAC Classical Swine Fever Vaccines Revenue (Million USD) and Gross Margin (2021-2026)
Table 45：Komipharm Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 46：Komipharm Classical Swine Fever Vaccines Product Features
Table 47：Komipharm Classical Swine Fever Vaccines Revenue (Million USD) and Gross Margin (2021-2026)
Table 48：Agrovet Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 49：Agrovet Classical Swine Fever Vaccines Product Features
Table 50：Agrovet Classical Swine Fever Vaccines Revenue (Million USD) and Gross Margin (2021-2026)
Table 51：Bioveta Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 52：Bioveta Classical Swine Fever Vaccines Product Features
Table 53：Bioveta Classical Swine Fever Vaccines Revenue (Million USD) and Gross Margin (2021-2026)
Table 54：Jinyu Bio-Technology Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 55：Jinyu Bio-Technology Classical Swine Fever Vaccines Product Features
Table 56：Jinyu Bio-Technology Classical Swine Fever Vaccines Revenue (Million USD) and Gross Margin (2021-2026)
Table 57：Institutul Pasteur Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 58：Institutul Pasteur Classical Swine Fever Vaccines Product Features
Table 59：Institutul Pasteur Classical Swine Fever Vaccines Revenue (Million USD) and Gross Margin (2021-2026)
Table 60：MVP Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 61：MVP Classical Swine Fever Vaccines Product Features
Table 62：MVP Classical Swine Fever Vaccines Revenue (Million USD) and Gross Margin (2021-2026)
Table 63：Global Classical Swine Fever Vaccines Market Size and Growth Forecast by Countries (2021 VS 2026 VS 2033) & (Million USD)
Table 64：Global Classical Swine Fever Vaccines Market Revenue by Countries (2021-2026) & (Million USD)
Table 65：Global Classical Swine Fever Vaccines Market Share by Countries (2021-2026)
Table 66：Global Classical Swine Fever Vaccines Market Revenue Forecast by Countries (2027-2033) & (Million USD)
Table 67：Global Classical Swine Fever Vaccines Market Share Forecast by Countries (2027-2033)
Table 68：Global Classical Swine Fever Vaccines Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 69：Global Classical Swine Fever Vaccines Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 70：Global Classical Swine Fever Vaccines Market Revenue by Product Application (2021-2026) & (Million USD)
Table 71：Global Classical Swine Fever Vaccines Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 72：United States Classical Swine Fever Vaccines Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 73：United States Classical Swine Fever Vaccines Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 74：United States Classical Swine Fever Vaccines Market Revenue by Product Application (2021-2026) & (Million USD)
Table 75：United States Classical Swine Fever Vaccines Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 76：China Classical Swine Fever Vaccines Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 77：China Classical Swine Fever Vaccines Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 78：China Classical Swine Fever Vaccines Market Revenue by Product Application (2021-2026) & (Million USD)
Table 79：China Classical Swine Fever Vaccines Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 80：Germany Classical Swine Fever Vaccines Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 81：Germany Classical Swine Fever Vaccines Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 82：Germany Classical Swine Fever Vaccines Market Revenue by Product Application (2021-2026) & (Million USD)
Table 83：Germany Classical Swine Fever Vaccines Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 84：Japan Classical Swine Fever Vaccines Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 85：Japan Classical Swine Fever Vaccines Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 86：Japan Classical Swine Fever Vaccines Market Revenue by Product Application (2021-2026) & (Million USD)
Table 87：Japan Classical Swine Fever Vaccines Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 88：France Classical Swine Fever Vaccines Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 89：France Classical Swine Fever Vaccines Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 90：France Classical Swine Fever Vaccines Market Revenue by Product Application (2021-2026) & (Million USD)
Table 91：France Classical Swine Fever Vaccines Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 92：South Korea Classical Swine Fever Vaccines Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 93：South Korea Classical Swine Fever Vaccines Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 94：South Korea Classical Swine Fever Vaccines Market Revenue by Product Application (2021-2026) & (Million USD)
Table 95：South Korea Classical Swine Fever Vaccines Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 96：United Kingdom Classical Swine Fever Vaccines Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 97：United Kingdom Classical Swine Fever Vaccines Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 98：United Kingdom Classical Swine Fever Vaccines Market Revenue by Product Application (2021-2026) & (Million USD)
Table 99：United Kingdom Classical Swine Fever Vaccines Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 100：India Classical Swine Fever Vaccines Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 101：India Classical Swine Fever Vaccines Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 102：India Classical Swine Fever Vaccines Market Revenue by Product Application (2021-2026) & (Million USD)
Table 103：India Classical Swine Fever Vaccines Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 104：Italy Classical Swine Fever Vaccines Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 105：Italy Classical Swine Fever Vaccines Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 106：Italy Classical Swine Fever Vaccines Market Revenue by Product Application (2021-2026) & (Million USD)
Table 107：Italy Classical Swine Fever Vaccines Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 108：Brazil Classical Swine Fever Vaccines Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 109：Brazil Classical Swine Fever Vaccines Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 110：Brazil Classical Swine Fever Vaccines Market Revenue by Product Application (2021-2026) & (Million USD)
Table 111：Brazil Classical Swine Fever Vaccines Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 112：Mexico Classical Swine Fever Vaccines Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 113：Mexico Classical Swine Fever Vaccines Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 114：Mexico Classical Swine Fever Vaccines Market Revenue by Product Application (2021-2026) & (Million USD)
Table 115：Mexico Classical Swine Fever Vaccines Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 116：Indonesia Classical Swine Fever Vaccines Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 117：Indonesia Classical Swine Fever Vaccines Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 118：Indonesia Classical Swine Fever Vaccines Market Revenue by Product Application (2021-2026) & (Million USD)
Table 119：Indonesia Classical Swine Fever Vaccines Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 120：Vietnam Classical Swine Fever Vaccines Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 121：Vietnam Classical Swine Fever Vaccines Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 122：Vietnam Classical Swine Fever Vaccines Market Revenue by Product Application (2021-2026) & (Million USD)
Table 123：Vietnam Classical Swine Fever Vaccines Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 124：South Africa Classical Swine Fever Vaccines Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 125：South Africa Classical Swine Fever Vaccines Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 126：South Africa Classical Swine Fever Vaccines Market Revenue by Product Application (2021-2026) & (Million USD)
Table 127：South Africa Classical Swine Fever Vaccines Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 128：Secondary Sources
Figure 1：Classical Swine Fever Vaccines Product Scope
Figure 2：Global Classical Swine Fever Vaccines Market Size and Growth Forecast Analysis (2021-2033) & (Million USD)
Figure 3：Global Classical Swine Fever Vaccines Product Segment Market Share (2026 & 2033)
Figure 4：Global Classical Swine Fever Vaccines Product Application Market Share (2026 & 2033)
Figure 5：C-Strain Live Attenuated Vaccine Product Scope
Figure 6：Thiverval Strain Vaccine Product Scope
Figure 7：Others Product Scope
Figure 8：Government Tender Product Scope
Figure 9：Market Sales Product Scope
Figure 10：Classical Swine Fever Vaccines Industrial Chain Framework
Figure 11：Global Classical Swine Fever Vaccines Market by Geographic Segmentation in 2026
Figure 12：Global Classical Swine Fever Vaccines Market Share by Countries (2021 VS 2026)
Figure 13：United States Classical Swine Fever Vaccines Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 14：China Classical Swine Fever Vaccines Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 15：Germany Classical Swine Fever Vaccines Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 16：Japan Classical Swine Fever Vaccines Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 17：France Classical Swine Fever Vaccines Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 18：South Korea Classical Swine Fever Vaccines Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 19：United Kingdom Classical Swine Fever Vaccines Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 20：India Classical Swine Fever Vaccines Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 21：Italy Classical Swine Fever Vaccines Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 22：Brazil Classical Swine Fever Vaccines Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 23：Mexico Classical Swine Fever Vaccines Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 24：Indonesia Classical Swine Fever Vaccines Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 25：Vietnam Classical Swine Fever Vaccines Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 26：South Africa Classical Swine Fever Vaccines Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 27：Research Methodology
Figure 28：Primary Sources
Figure 29：Data Cross Validation
Global Classical Swine Fever Vaccines Revenue and Market Share by Key Players
| Revenue (US$ Million) | 2021 | 2022 | 2023 | 2024 | 2025 |
| Winsun Bio-Pharmaceutical | XX | XX | XX | XX | XX |
| MSD Animal Health | XX | XX | XX | XX | XX |
| CAHIC | XX | XX | XX | XX | XX |
| Tecon | XX | XX | XX | XX | XX |
| SPAH | XX | XX | XX | XX | XX |
| Boehringer Ingelheim | XX | XX | XX | XX | XX |
| Ceva | XX | XX | XX | XX | XX |
| Harbin Weike BIOTECHNOLOGY | XX | XX | XX | XX | XX |
| Qilu Animal Health Products | XX | XX | XX | XX | XX |
| Ringpu Bio-Technology | XX | XX | XX | XX | XX |
| DaHuaNong Animal Health Products | XX | XX | XX | XX | XX |
| CAVAC | XX | XX | XX | XX | XX |
| Komipharm | XX | XX | XX | XX | XX |
| Agrovet | XX | XX | XX | XX | XX |
| Bioveta | XX | XX | XX | XX | XX |
| Jinyu Bio-Technology | XX | XX | XX | XX | XX |
| Institutul Pasteur | XX | XX | XX | XX | XX |
| MVP | XX | XX | XX | XX | XX |
| Other Companies | XX | XX | XX | XX | XX |
| Total | XX | XX | XX | XX | XX |
English
Related Reports 
